Unusual presentation of Waldenstrom macroglobulinemia

[1]  K. Young,et al.  Waldenström macroglobulinemia with extramedullary involvement at initial diagnosis portends a poorer prognosis , 2015, Journal of Hematology & Oncology.

[2]  J. Laubach,et al.  Extramedullary Waldenström macroglobulinemia , 2015, American journal of hematology.

[3]  M. Lai,et al.  Incidence of lymphoplasmacytic lymphoma/Waldenström's macroglobulinaemia in Japan and Taiwan population‐based cancer registries, 1996–2003 , 2014, International journal of cancer.

[4]  M. Gertz.  Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management , 2013, American journal of hematology.

[5]  R. Vij,et al.  Waldenström macroglobulinemia: a Surveillance, Epidemiology, and End Results database review from 1988 to 2005 , 2012, Leukemia & lymphoma.

[6]  E. Kimby,et al.  Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  D. Weisenburger,et al.  Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). , 2007, Blood.

[8]  D. Weisenburger,et al.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. , 2006, Blood.

[9]  P. Morel,et al.  Report of the Third International Workshop on Waldenstrom's macroglobulinemia. , 2005, Clinical lymphoma.

[10]  L. Medeiros,et al.  Waldenstrom Macroglobulinemia Involving Extramedullary Sites: Morphologic and Immunophenotypic Findings in 44 Patients , 2003, The American journal of surgical pathology.